nach oben

Pediatric Surgery International

Erschienen in:

01.12.2023 | Review Article

Role of surgery in neuroblastoma

verfasst von: Akihiro Yoneda

Erschienen in: Pediatric Surgery International | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Neuroblastoma is the most common malignant solid tumor handled by pediatric surgeons. It is well-known that neuroblastoma shows variable biological and clinical behaviors. In this review article, surgical strategy in neuroblastoma was described by risk stratification. Also, strategy of biopsy and clinical conditions that require special considerations such as neuroblastoma detected by mass screening, relapsed neuroblastoma, patients with stage MS and dumbbell type tumors was mentioned. As multimodal systemic treatments have been expanding, the role of surgery in neuroblastoma has become relatively less significant but requisite. We surgeons should decide therapeutic strategy based on the correct understanding of biology of neuroblastoma thinking of the better future of children.

Evans AE, D’Angio GJ, Randolph J (1971) A proposed staging for children with neuroblastoma. Child Cancer Study Group A Cancer 27:374–378

Yoneda A, Oue T, Imura K, Inoue M, Yagi K, Kawa K, Nishikawa M, Morimoto S, Nakayama M (2001) Observation of untreated patients with neuroblastoma detected by mass screening: a “wait and see” pilot study. Med Pediatr Oncol 36:160–162CrossRefPubMed

Nishihira H, Toyoda Y, Tanaka Y, Ijiri R, Aida N, Takeuchi M, Ohnuma K, Kigasawa H, Kato K, Nishi T (2000) Natural course of neuroblastoma detected by mass screening: a 5-year prospective study at a single institution. J Clin Oncol 18:3012–3017CrossRefPubMed

Yamamoto K, Hanada R, Tanimura M, Aihara T, Hayashi Y (1997) Natural history of neuroblastoma found by mass screening. Lancet 349:1102CrossRefPubMed

Matthay KK, Shulkin B, Ladenstein R, Michon J, Giammarile F, Lewington V, Pearson AD, Cohn SL (2010) Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. Br J Cancer 102:1319–1326. https://doi.org/10.1038/sj.bjc.6605621CrossRefPubMedPubMedCentral

Vo KT, DuBois SG, Neuhaus J, Braunstein SE, Weil BR, Naranjo A, Irtan S, Balaguer J, Matthay KK (2022) Pattern and predictors of sites of relapse in neuroblastoma: a report from the international neuroblastoma risk group (INRG) project. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.29616CrossRefPubMedPubMedCentral

Yu AL, Gilman AL, Ozkaynak MF, Naranjo A, Diccianni MB, Gan J, Hank JA, Batova A, London WB, Tenney SC, Smith M, Shulkin BL, Parisi M, Matthay KK, Cohn SL, Maris JM, Bagatell R, Park JR, Sondel PM (2021) Long-Term follow-up of a phase III study of ch14.18 (Dinutuximab) + cytokine immunotherapy in children with high-risk neuroblastoma: COG study ANBL0032. Clin Cancer Res 27:2179–2189. https://doi.org/10.1158/1078-0432.CCR-20-3909CrossRefPubMedPubMedCentral

Park JR, Kreissman SG, London WB, Naranjo A, Cohn SL, Hogarty MD, Tenney SC, Haas-Kogan D, Shaw PJ, Kraveka JM, Roberts SS, Geiger JD, Doski JJ, Voss SD, Maris JM, Grupp SA, Diller L (2019) Effect of tandem autologous stem cell transplant vs single transplant on event-free survival in patients with high-risk neuroblastoma: a randomized clinical trial. JAMA 322:746–755. https://doi.org/10.1001/jama.2019.11642CrossRefPubMedPubMedCentral

Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK (2009) The International neuroblastoma risk group (INRG) classification system: an INRG task force report. J Clin Oncol 27:289–297. https://doi.org/10.1200/JCO.2008.16.6785CrossRefPubMedPubMedCentral

10.

Matthay KK, Sather HN, Seeger RC, Haase GM, Hammond GD (1989) Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7:236–244CrossRefPubMed

11.

Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, Schwabe D, Schilling FH, Benz-Bohm G, Berthold F (2008) Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol 26:1504–1510. https://doi.org/10.1200/JCO.2007.12.3349CrossRefPubMed

12.

Iehara T, Yagyu S, Tsuchiya K, Kuwahara Y, Miyachi M, Tajiri T, Sugimoto T, Sawada T, Hosoi H (2016) Residual tumor in cases of intermediate-risk neuroblastoma did not influence the prognosis. Jpn J Clin Oncol 46:661–666. https://doi.org/10.1093/jjco/hyw050CrossRefPubMed

13.

Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson AD (2009) The international neuroblastoma risk group (INRG) staging system: an INRG task force report. J Clin Oncol 27:298–303. https://doi.org/10.1200/JCO.2008.16.6876CrossRefPubMed

14.

Cecchetto G, Mosseri V, De Bernardi B, Helardot P, Monclair T, Costa E, Horcher E, Neuenschwander S, Toma P, Rizzo A, Michon J, Holmes K (2005) Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol 23:8483–8489CrossRefPubMed

15.

Iehara T, Yoneda A, Yokota I, Takahashi H, Teramukai S, Kamijyo T, Nakazawa A, Takimoto T, Kikuta A, Yagyu S, Ikeda H, Nakagawara A, Tajiri T, Japan Childhood Cancer Group Neuroblastoma C (2019) Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: a report from the Japan Children’s Cancer Group Neuroblastoma Committee. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.27914CrossRefPubMed

16.

Iehara T, Yoneda A, Kikuta A, Muraji T, Tokiwa K, Takahashi H, Teramukai S, Takimoto T, Yagyu S, Hosoi H, Tajiri T, Japan Children’s Cancer Group Neuroblastoma C (2020) A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: a study protocol. BMC Pediatr 20:212. https://doi.org/10.1186/s12887-020-02061-5CrossRefPubMed

17.

Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, Giammarile F, Schmidt M, Shulkin BL, Matthay KK, Lewington VJ, Sarnacki S, Hero B, Kaneko M, London WB, Pearson AD, Cohn SL, Monclair T (2011) Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 261:243–257. https://doi.org/10.1148/radiol.11101352CrossRefPubMed

18.

Yoneda A, Nishikawa M, Uehara S, Oue T, Usui N, Inoue M, Fukuzawa M, Okuyama H (2016) Can image-defined risk factors predict surgical complications in localized neuroblastoma? Eur J Pediatr Surg 26:117–122. https://doi.org/10.1055/s-0035-1566100CrossRefPubMed

19.

Yoneda A, Nishikawa M, Uehara S, Oue T, Usui N, Inoue M, Fukuzawa M, Okuyama H (2016) Can neoadjuvant chemotherapy reduce the surgical risks for localized neuroblastoma patients with image-defined risk factors at the time of diagnosis? Pediatr Surg Int. https://doi.org/10.1007/s00383-016-3858-5CrossRefPubMed

20.

Simon T, Haberle B, Hero B, von Schweinitz D, Berthold F (2013) Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol 31:752–758. https://doi.org/10.1200/JCO.2012.45.9339CrossRefPubMed

21.

Fischer J, Pohl A, Volland R, Hero B, Dubbers M, Cernaianu G, Berthold F, von Schweinitz D, Simon T (2017) Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months. BMC Cancer 17:520. https://doi.org/10.1186/s12885-017-3493-0CrossRefPubMedPubMedCentral

22.

von Allmen D, Davidoff AM, London WB, Van Ryn C, Haas-Kogan DA, Kreissman SG, Khanna G, Rosen N, Park JR, La Quaglia MP (2017) Impact of extent of resection on local control and survival in patients from the COG A3973 study with high-risk neuroblastoma. J Clin Oncol 35:208–216. https://doi.org/10.1200/JCO.2016.67.2642CrossRef

23.

Holmes K, Potschger U, Pearson ADJ, Sarnacki S, Cecchetto G, Gomez-Chacon J, Squire R, Freud E, Bysiek A, Matthyssens LE, Metzelder M, Monclair T, Stenman J, Rygl M, Rasmussen L, Joseph JM, Irtan S, Avanzini S, Godzinski J, Bjornland K, Elliott M, Luksch R, Castel V, Ash S, Balwierz W, Laureys G, Ruud E, Papadakis V, Malis J, Owens C, Schroeder H, Beck-Popovic M, Trahair T, Forjaz de Lacerda A, Ambros PF, Gaze MN, McHugh K, Valteau-Couanet D, Ladenstein RL, International Society of Paediatric Oncology Europe Neuroblastoma G (2020) influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma: a report from the HR-NBL1/SIOPEN study. J Clin Oncol 38:2902–2915. https://doi.org/10.1200/JCO.19.03117CrossRefPubMed

24.

Hara J, Nitani C, Shichino H, Kuroda T, Hishiki T, Soejima T, Mori T, Matsumoto K, Sasahara Y, Iehara T, Miyamura T, Kosaka Y, Takimoto T, Nakagawara A, Tajiri T, Japan Children’s Cancer Group Neuroblastoma C (2022) Outcome of children with relapsed high-risk neuroblastoma in Japan and analysis of the role of allogeneic hematopoietic stem cell transplantation. Jpn J Clin Oncol. https://doi.org/10.1093/jjco/hyac007CrossRefPubMed

25.

Hashii Y, Kusafuka T, Ohta H, Yoneda A, Osugi Y, Kobayashi Y, Fukuzawa M, Hara J (2008) A case series of children with high-risk metastatic neuroblastoma treated with a novel treatment strategy consisting of postponed primary surgery until the end of systemic chemotherapy including high-dose chemotherapy. Pediatr Hematol Oncol 25:439–450. https://doi.org/10.1080/08880010802104601CrossRefPubMed

26.

Uehara S, Yoneda A, Oue T, Nakahata K, Zenitani M, Miyamura T, Hashii Y, Fukuzawa M, Okuyama H (2017) The role of surgery in delayed local treatment for INSS 4 neuroblastoma. Pediatr Int. https://doi.org/10.1111/ped.13349CrossRefPubMed

27.

Ambros PF, Ambros IM (2001) Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol 37:492–504CrossRefPubMed

28.

Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, Schleiermacher G, Speleman F, Spitz R, London WB, Cohn SL, Pearson AD, Maris JM (2009) International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer 100:1471–1482. https://doi.org/10.1038/sj.bjc.6605014CrossRefPubMedPubMedCentral

29.

Hassan SF, Mathur S, Magliaro TJ, Larimer EL, Ferrell LB, Vasudevan SA, Patterson DM, Louis CU, Russell HV, Nuchtern JG, Kim ES (2012) Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children. J Pediatr Surg 47:1261–1266. https://doi.org/10.1016/j.jpedsurg.2012.03.040CrossRefPubMed

30.

Iehara T, Yagyu S, Gotoh T, Ouchi K, Yoshida H, Miyachi M, Kikuchi K, Sugimoto T, Hosoi H (2019) A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patients. Jpn J Clin Oncol 49:743–748. https://doi.org/10.1093/jjco/hyz063CrossRefPubMed

31.

Sawada T, Hirayama M, Nakata T, Takeda T, Takasugi N, Mori T, Maeda K, Koide R, Hanawa Y, Tsunoda A et al (1984) Mass screening for neuroblastoma in infants in Japan Interim report of a mass screening study group. Lancet 2:271–273CrossRefPubMed

32.

Hiyama E, Iehara T, Sugimoto T, Fukuzawa M, Hayashi Y, Sasaki F, Sugiyama M, Kondo S, Yoneda A, Yamaoka H, Tajiri T, Akazawa K, Ohtaki M (2008) Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study. Lancet 371:1173–1180. https://doi.org/10.1016/S0140-6736(08)60523-1CrossRefPubMed

33.

Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F et al (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466–1477CrossRefPubMed

34.

De Bernardi B, Pianca C, Pistamiglio P, Veneselli E, Viscardi E, Pession A, Alvisi P, Carli M, Donfrancesco A, Casale F, Giuliano MG, di Montezemolo LC, Di Cataldo A, Lo Curto M, Bagnulo S, Schumacher RF, Tamburini A, Garaventa A, Clemente L, Bruzzi P (2001) Neuroblastoma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 cases. J Clin Oncol 19:183–190CrossRef

35.

Kraal K, Blom T, Tytgat L, van Santen H, van Noesel M, Smets A, Bramer J, Caron H, Kremer L, van der Pal H (2016) Neuroblastoma with intraspinal extension: health problems in long-term survivors. Pediatr Blood Cancer 63:990–996. https://doi.org/10.1002/pbc.25925CrossRefPubMed

36.

Kraal K, Blom T, van Noesel M, Kremer L, Caron H, Tytgat G, van der Pal H (2017) Treatment and outcome of neuroblastoma with intraspinal extension: a systematic review. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.26451CrossRefPubMed

Titel: Role of surgery in neuroblastoma
verfasst von: Akihiro Yoneda
Publikationsdatum: 01.12.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Pediatric Surgery International / Ausgabe 1/2023
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI: https://doi.org/10.1007/s00383-023-05459-1

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Role of surgery in neuroblastoma

Abstract

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Treatment and follow-up of late onset intra hepatic bile duct stones in congenital biliary dilatation

Gastroschisis in Mozambique: current status and priorities for improving care from Hospital Central de Maputo, the largest and referral hospital of the country

Intraoperative OK-432 pleurodesis for preventing recurrence of primary spontaneous pneumothorax in children and adolescents: a single-center experience

Peripherally inserted central catheters can be an alternative to tunneled central venous catheters in chemotherapy for hematological and oncological pediatric patients

Tracheal reconstruction surgery for congenital tracheal stenosis

Recurrence rates following ileo-colic resection in pediatric patients with Crohn’s disease

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie